Christina Sundal

6PUBLICATIONS
62CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Traditional Chinese medicine and treatmentsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 06, 2026
Triple Preventive Therapy with OnabotulinumtoxinA, Fremanezumab, and Atogepant in Treatment-Resistant Chronic Migraine: A 52-Week Pilot Case Series (TRIPLE Cohort).

|Jun 19, 2026
Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort.

|Jan 28, 2026
Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Edoardo Caronna, Rut Mas-de-Les-Valls, Gabriella Egeo

|Dec 02, 2025
Combination preventive therapy with onabotulinumtoxinA and atogepant for chronic migraine: A 24-week, prospective, real-world evaluation (SYNERGY study).

Luigi Francesco Iannone, Marina Romozzi, Antonio Russo

|Aug 28, 2025
Effectiveness and tolerability of atogepant as preventive treatment in resistant individuals with chronic migraine: Six-month real-world evidence.

Antonio Russo, Marcello Silvestro, Ian Finkelstein

Pageof 1

Frequent Collaborators

5 joint publications

Edoardo Caronna

5 joint publications

Patricia Pozo-Rosich

4 joint publications

Erling Tronvik

3 joint publications

Alicia Alpuente